Integration of Matrisome Omics: Towards System Biology of the Tumor Matrisome

Part of the Biology of Extracellular Matrix book series (BEM, volume 7)


The tumor matrisome, the collection of structural and functional extracellular matrix (ECM) proteins found in tumors together with ECM-associated proteins, growth factors, cytokines and chemokines is an extremely dynamic entity whose composition and regulation depends on both local, cell-specific processes and overarching pan-cancer microenvironmental landscapes. A deeper knowledge and understanding of the tumor matrisome would grant us novel diagnostic, prognostic and therapeutic possibilities but to reach that point there is a pressing need to combine fine-grained molecular studies with system biology approaches to build a complete map of what actually happens in the tumor microenvironment. In this chapter, we will review the most salient findings on the tumor matrisome at the transcriptomics, regulomics and proteomics level and show how the use of big data enables the identification of biological features and characteristics that cross different tumors and the discovery of novel molecular mechanisms connecting the different omics level. Also, we will provide a simple walkthrough to jumpstart matrisome data analysis for complete beginners in a bid to ignite more research in this fascinating field.


  1. Aebersold R, Mann M (2003) Mass spectrometry-based proteomics. Nature 422:198–207PubMedGoogle Scholar
  2. Anastassiou D (2017) Cancer letters. Cancer Lett 393:125–126PubMedGoogle Scholar
  3. Andriani F, Landoni E, Mensah M, Facchinetti F, Miceli R, Tagliabue E, Giussani M, Callari M, De Cecco L, Colombo MP et al (2018) Diagnostic role of circulating extracellular matrix-related proteins in non-small cell lung cancer. BMC Cancer 18:899PubMedPubMedCentralGoogle Scholar
  4. Bailey MH, Tokheim C, Porta-Pardo E, Sengupta S, Bertrand D, Weerasinghe A, Colaprico A, Wendl MC, Kim J, Reardon B et al (2018) Comprehensive characterization of Cancer driver genes and mutations. Cell 173:371–385.e18PubMedPubMedCentralGoogle Scholar
  5. Bansal AK, Singh LR, Kamli MR (2019) Chapter 9 – Posttranslational modifications associated with Cancer and their therapeutic implications. In: Dar TA, Singh LR (eds) Protein modificomics. Academic Press, Cambridge, pp 203–227Google Scholar
  6. Bao Y, Wang L, Shi L, Yun F, Liu X, Chen Y, Chen C, Ren Y, Jia Y (2019) Transcriptome profiling revealed multiple genes and ECM-receptor interaction pathways that may be associated with breast cancer. Cell Mol Biol Lett 24:38PubMedPubMedCentralGoogle Scholar
  7. Baroncelli M, van der Eerden BCJ, Chatterji S, Rull Trinidad E, Kan YY, Koedam M, van Hengel IAJ, Alves RDAM, Fratila-Apachitei LE, Demmers JAA, van de Peppel J, van Leeuwen JPTM (2018) Human osteoblast-derived extracellular matrix with high homology to bone proteome is Osteopromotive. Tissue Eng Part A 24:1377–1389PubMedGoogle Scholar
  8. Barrett AS, Maller O, Pickup MW, Weaver VM, Hansen KC (2018) Compartment resolved proteomics reveals a dynamic matrisome in a biomechanically driven model of pancreatic ductal adenocarcinoma. J Immunol Regen Med 1:67–75Google Scholar
  9. Bartoschek M, Oskolkov N, Bocci M, Lövrot J, Larsson C, Sommarin M, Madsen CD, Lindgren D, Pekar G, Karlsson G et al (2018) Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing. Nat Commun 9:1–13Google Scholar
  10. Bergamaschi A, Tagliabue E, Sørlie T, Naume B, Triulzi T, Orlandi R, Russnes HG, Nesland JM, Tammi R, Auvinen P et al (2008) Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome. J Pathol 214:357–367PubMedGoogle Scholar
  11. Bradner JE, Hnisz D, Young RA (2017) Transcriptional addiction in Cancer. Cell 168:629–643PubMedPubMedCentralGoogle Scholar
  12. Brandt S, Montagna C, Georgis A, Schüffler PJ, Bühler MM, Seifert B, Thiesler T, Curioni-Fontecedro A, Hegyi I, Dehler S et al (2013) The combined expression of the stromal markers fibronectin and SPARC improves the prediction of survival in diffuse large B-cell lymphoma. Exp Hematol Oncol 2:27PubMedPubMedCentralGoogle Scholar
  13. Brassart-Pasco S, Brézillon S, Brassart B, Ramont L, Oudart J, Monboisse JC (2020) Tumor microenvironment: extracellular matrix alterations influence tumor progression. Front Oncol 10:397PubMedPubMedCentralGoogle Scholar
  14. Brechbuhl HM, Barrett AS, Kopin E, Hagen JC, Han AL, Gillen AE, Finlay-Schultz J, Cittelly DM, Owens P, Horwitz KB et al (2020) Fibroblast subtypes define a metastatic matrisome in breast cancer. JCI Insight 5(4)Google Scholar
  15. Carpino G, Overi D, Melandro F, Grimaldi A, Cardinale V, Di Matteo S, Mennini G, Rossi M, Alvaro D, Barnaba V, Gaudio E, Mancone C (2019) Matrisome analysis of intrahepatic cholangiocarcinoma unveils a peculiar cancer-associated extracellular matrix structure. Clin Proteomics 16:37PubMedPubMedCentralGoogle Scholar
  16. Casamassimi A, Ciccodicola A (2019) Transcriptional regulation: molecules, involved mechanisms, and Misregulation. Int J Mol Sci 20:1281PubMedCentralGoogle Scholar
  17. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E et al (2012) The cBio Cancer genomics portal: an open platform for exploring multidimensional Cancer genomics data. Cancer Discov 2:401–404PubMedGoogle Scholar
  18. Cerchietti L, Inghirami G, Kotlov N, Svekolkin V, Bagaev A, Frenkel F, Revuelta MV, Phillip JM, Cacciapuoti MT, Rutherford SC, Martin P, Leonard JP (2019) Microenvironmental signatures reveal biological subtypes of diffuse large B-cell lymphoma (DLBCL) distinct from tumor cell molecular profiling. Blood 134:656–656Google Scholar
  19. Chakravarthy A, Khan L, Bensler NP, Bose P, De Carvalho DD (2018) TGF-β-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure. Nat Commun 9(1).
  20. Cheon D, Tong Y, Sim M, Dering J, Berel D, Cui X, Lester J, Beach JA, Tighiouart M, Walts AE, Karlan BY, Orsulic S (2014) A collagen-remodeling gene signature regulated by TGF-β signaling is associated with metastasis and poor survival in serous ovarian cancer. Clin Cancer Res 20:711–723PubMedGoogle Scholar
  21. Chick JM, Kolippakkam D, Nusinow DP, Zhai B, Rad R, Huttlin EL, Gygi SP (2015) A mass-tolerant database search identifies a large proportion of unassigned spectra in shotgun proteomics as modified peptides. Nat Biotechnol 33:743–749PubMedPubMedCentralGoogle Scholar
  22. Ciasca G, Sassun TE, Minelli E, Antonelli M, Papi M, Santoro A, Giangaspero F, Delfini R, De Spirito M (2016) Nano-mechanical signature of brain tumours. Nanoscale 8:19629–19643PubMedGoogle Scholar
  23. Cox J, Hein MY, Luber CA, Paron I, Nagaraj N, Mann M (2014) Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol Cell Proteomics 13:2513–2526PubMedPubMedCentralGoogle Scholar
  24. Cox TR, Rumney RMH, Schoof EM, Perryman L, Høye AM, Agrawal A, Bird D, Latif NA, Forrest H, Evans HR et al (2015) The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase. Nature 522:106–110PubMedPubMedCentralGoogle Scholar
  25. Deutsch EW, Csordas A, Sun Z, Jarnuczak A, Perez-Riverol Y, Ternent T, Campbell DS, Bernal-Llinares M, Okuda S, Kawano S et al (2017) The ProteomeXchange consortium in 2017: supporting the cultural change in proteomics public data deposition. Nucleic Acids Res 45:D1100–D1106PubMedGoogle Scholar
  26. Dong L, Ma L, Ma GH, Ren H (2019) Genome-wide analysis reveals DNA methylation alterations in obesity associated with high risk of colorectal Cancer. Sci Rep 9:5100PubMedPubMedCentralGoogle Scholar
  27. Editorial (2020) The era of massive cancer sequencing projects has reached a turning point. Nature 578:7–8Google Scholar
  28. Edwards NJ, Oberti M, Thangudu RR, Cai S, McGarvey PB, Jacob S, Madhavan S, Ketchum KA (2015) The CPTAC data portal: A resource for Cancer proteomics research. J Proteome Res 14:2707–2713PubMedGoogle Scholar
  29. Finkernagel F, Reinartz S, Lieber S, Adhikary T, Wortmann A, Hoffmann N, Bieringer T, Nist A, Stiewe T, Jansen JM et al (2016) The transcriptional signature of human ovarian carcinoma macrophages is associated with extracellular matrix reorganization. Oncotarget 7:75339–75352PubMedPubMedCentralGoogle Scholar
  30. Foroushani A, Agrahari R, Docking R, Chang L, Duns G, Hudoba M, Karsan A, Zare H (2017) Large-scale gene network analysis reveals the significance of extracellular matrix pathway and homeobox genes in acute myeloid leukemia: an introduction to the Pigengene package and its applications. BMC Med Genet 10:16–16Google Scholar
  31. Frezzetti D, De Luca A, Normanno N (2019) Extracellular matrix proteins as circulating biomarkers for the diagnosis of non-small cell lung cancer patients. J Thorac Dis 11:S1252–S1256PubMedPubMedCentralGoogle Scholar
  32. Fu Y, Feng M, Yu J, Ma M, Liu X, Li J, Yang X, Wang Y, Zhang Y, Ao J et al (2014) DNA methylation-mediated silencing of matricellular protein dermatopontin promotes hepatocellular carcinoma metastasis by α3β1 integrin-rho GTPase signaling. Oncotarget 5:6701–6715PubMedPubMedCentralGoogle Scholar
  33. Gao GF, Parker JS, Reynolds SM, Silva TC, Wang L, Zhou W, Akbani R, Bailey M, Balu S, Berman BP et al (2019) Before and after: comparison of legacy and harmonized TCGA genomic data commons’ data. Cell Syst 9:24–34.e10PubMedPubMedCentralGoogle Scholar
  34. Ghedira K (2018) Introductory chapter: a brief overview of transcriptional and post-transcriptional regulation. Transcriptional and Post-Transcriptional RegulationGoogle Scholar
  35. Glatter T, Ludwig C, Ahrné E, Aebersold R, Heck AJR, Schmidt A (2012) Large-scale quantitative assessment of different in-solution protein digestion protocols reveals superior cleavage efficiency of tandem Lys-C/trypsin proteolysis over trypsin digestion. J Proteome Res 11:5145–5156PubMedGoogle Scholar
  36. Glavey SV, Naba A, Manier S, Clauser K, Tahri S, Park J, Reagan MR, Moschetta M, Mishima Y, Gambella M et al (2017) Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. Leukemia 31:2426–2434PubMedGoogle Scholar
  37. Gocheva V, Naba A, Bhutkar A, Guardia T, Miller KM, Li CM, Dayton TL, Sanchez-Rivera FJ, Kim-Kiselak C, Jailkhani N et al (2017) Quantitative proteomics identify tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival. Proc Natl Acad Sci U S A 114:E5625–E5634PubMedPubMedCentralGoogle Scholar
  38. Heilmann K, Toth R, Bossmann C, Klimo K, Plass C, Gerhauser C (2017) Genome-wide screen for differentially methylated long noncoding RNAs identifies Esrp2 and lncRNA Esrp2-as regulated by enhancer DNA methylation with prognostic relevance for human breast cancer. Oncogene 36:6446–6461PubMedPubMedCentralGoogle Scholar
  39. Helleman J, Jansen MPHM, Ruigrok-Ritstier K, van Staveren IL, Look MP, Meijer-van Gelder ME, Sieuwerts AM, Klijn JGM, Sleijfer S, Foekens JA, Berns EMJJ (2008) Association of an Extracellular Matrix Gene Cluster with breast Cancer prognosis and endocrine therapy response. Clin Cancer Res 14:5555–5564PubMedGoogle Scholar
  40. Henke E, Nandigama R, Ergün S (2020) Extracellular matrix in the tumor microenvironment and its impact on Cancer therapy. Front Mol Biosci 6:160PubMedPubMedCentralGoogle Scholar
  41. Hinshaw DC, Shevde LA (2019) The tumor microenvironment innately modulates Cancer progression. Cancer Res 79:4557–4566PubMedPubMedCentralGoogle Scholar
  42. Hoadley KA, Yau C, Wolf DM, Cherniack AD, Tamborero D, Ng S, Leiserson MDM, Niu B, McLellan MD, Uzunangelov V et al (2014) Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell 158:929–944PubMedPubMedCentralGoogle Scholar
  43. Hoadley KA, Yau C, Hinoue T, Wolf DM, Lazar AJ, Drill E, Shen R, Taylor AM, Cherniack AD, Thorsson V et al (2018) Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of Cancer. Cell 173:291–304.e6PubMedPubMedCentralGoogle Scholar
  44. Huang K, Mashl RJ, Wu Y, Ritter DI, Wang J, Oh C, Paczkowska M, Reynolds S, Wyczalkowski MA, Oak N et al (2018) Pathogenic germline variants in 10,389 adult cancers. Cell 173:355–370.e14PubMedPubMedCentralGoogle Scholar
  45. Izzi V, Lakkala J, Devarajan R, Ruotsalainen H, Savolainen ER, Koistinen P, Heljasvaara R, Pihlajaniemi T (2017a) An extracellular matrix signature in leukemia precursor cells and acute myeloid leukemia. Haematologica 102:e245–e248PubMedPubMedCentralGoogle Scholar
  46. Izzi V, Lakkala J, Devarajan R, Ruotsalainen H, Savolainen ER, Koistinen P, Heljasvaara R, Pihlajaniemi T (2017b) An extracellular matrix signature in leukemia precursor cells and acute myeloid leukemia. Haematologica 102:1807–1809PubMedPubMedCentralGoogle Scholar
  47. Izzi V, Lakkala J, Devarajan R, Savolainen ER, Koistinen P, Heljasvaara R, Pihlajaniemi T (2017c) Expression of a specific extracellular matrix signature is a favorable prognostic factor in acute myeloid leukemia. Leuk Res Rep 9:9–13PubMedPubMedCentralGoogle Scholar
  48. Izzi V, Lakkala J, Devarajan R, Kääriäinen A, Koivunen J, Heljasvaara R, Pihlajaniemi T (2019) Pan-Cancer analysis of the expression and regulation of matrisome genes across 32 tumor types. Matrix Biology Plus 1:100004Google Scholar
  49. Izzi V, Heljasvaara R, Heikkinen A, Karppinen S, Koivunen J, Pihlajaniemi T (2020) Exploring the roles of MACIT and multiplexin collagens in stem cells and cancer. Semin Cancer Biol 62:134–148PubMedGoogle Scholar
  50. Jansen M, Foekens J, Van Staveren I, Dirkszwager-Kiel M, Ritstier K, Look M, Meijer-Van Gelder M, Portengen H, Dorssers L, Klijn J, Berns E (2004) Molecular classification of tamoxifen resistant breast carcinomas by gene expression profiling. Cancer Res 64:657Google Scholar
  51. Jia D, Liu Z, Deng N, Tan TZ, Huang RY, Taylor-Harding B, Cheon DJ, Lawrenson K, Wiedemeyer WR, Walts AE, Karlan BY, Orsulic S (2016) A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets. Cancer Lett 382:203–214PubMedPubMedCentralGoogle Scholar
  52. Jinka R, Kapoor R, Sistla PG, Raj TA, Pande G (2012) Alterations in cell-extracellular matrix interactions during progression of cancers. Int J Cell Biol 2012:219196PubMedPubMedCentralGoogle Scholar
  53. Ju Q, Zhao Y, Dong Y, Cheng C, Zhang S, Yang Y, Li P, Ge D, Sun B (2019) Identification of a miRNA-mRNA network associated with lymph node metastasis in colorectal cancer. Oncol Lett 18:1179–1188PubMedPubMedCentralGoogle Scholar
  54. Kim H, Watkinson J, Varadan V, Anastassiou D (2010) Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1. BMC Med Genet 3:51Google Scholar
  55. Kobayashi N, Oda T, Takizawa M, Ishizaki T, Tsukamoto N, Yokohama A, Takei H, Saitoh T, Shimizu H, Honma K et al (2020) Integrin α7 and extracellular matrix laminin 211 interaction promotes proliferation of acute myeloid leukemia cells and is associated with granulocytic sarcoma. Cancers (Basel) 12:363Google Scholar
  56. Krasny L, Paul A, Wai P, Howard BA, Natrajan RC, Huang PH (2016) Comparative proteomic assessment of matrisome enrichment methodologies. Biochem J 473:3979–3995PubMedPubMedCentralGoogle Scholar
  57. Krüger M, Moser M, Ussar S, Thievessen I, Luber CA, Forner F, Schmidt S, Zanivan S, Fässler R, Mann M (2008) SILAC mouse for quantitative proteomics uncovers Kindlin-3 as an essential factor for red blood cell function. Cell 134:353–364PubMedGoogle Scholar
  58. Lavanya V, Jamal S, Ahmed N (2019) Chapter 5 – Ubiquitin mediated posttranslational modification of proteins involved in various signaling diseases. In: Dar TA, Singh LR (eds) Protein modificomics. Academic Press, Cambridge, pp 109–130Google Scholar
  59. Lee KJ, Comerford EJ, Simpson DM, Clegg PD, Canty-Laird EG (2019) Identification and characterization of canine ligament progenitor cells and their extracellular matrix niche. J Proteome Res 18:1328–1339PubMedGoogle Scholar
  60. Lelli KM, Slattery M, Mann RS (2012) Disentangling the many layers of eukaryotic transcriptional regulation. Annu Rev Genet 46:43–68PubMedPubMedCentralGoogle Scholar
  61. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, Fong SFT, Csiszar K, Giaccia A, Weninger W et al (2009) Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139:891–906PubMedPubMedCentralGoogle Scholar
  62. Li S, Christiansen L, Christensen K, Kruse TA, Redmond P, Marioni RE, Deary IJ, Tan Q (2017) Identification, replication and characterization of epigenetic remodelling in the aging genome: a cross population analysis. Sci Rep 7:8183PubMedPubMedCentralGoogle Scholar
  63. Li J, Wang W, Xia P, Wan L, Zhang L, Yu L, Wang L, Chen X, Xiao Y, Xu C (2018) Identification of a five-lncRNA signature for predicting the risk of tumor recurrence in patients with breast cancer. Int J Cancer 143:2150–2160PubMedPubMedCentralGoogle Scholar
  64. Lim SB, Tan SJ, Lim WT, Lim CT (2017) An extracellular matrix-related prognostic and predictive indicator for early-stage non-small cell lung cancer. Nat Commun 8:1734–1736PubMedPubMedCentralGoogle Scholar
  65. Lim SB, Tan SJ, Lim W, Lim CT (2018) A merged lung cancer transcriptome dataset for clinical predictive modeling. Scientific Data 5:180136PubMedPubMedCentralGoogle Scholar
  66. Lim SB, Yeo T, Lee WD, Bhagat AAS, Tan SJ, Tan DSW, Lim W, Lim CT (2019) Addressing cellular heterogeneity in tumor and circulation for refined prognostication. Proc Natl Acad Sci U S A 116:17957–17962PubMedPubMedCentralGoogle Scholar
  67. Malandrino A, Mak M, Kamm RD, Moeendarbary E (2018) Complex mechanics of the heterogeneous extracellular matrix in cancer. Extreme Mech Lett 21:25–34PubMedPubMedCentralGoogle Scholar
  68. Malta TM, Sokolov A, Gentles AJ, Burzykowski T, Poisson L, Weinstein JN, Kamińska B, Huelsken J, Omberg L, Gevaert O et al (2018) Machine learning identifies Stemness features associated with oncogenic dedifferentiation. Cell 173:338–354.e15PubMedPubMedCentralGoogle Scholar
  69. Mao Y, Block T, Singh-Varma A, Sheldrake A, Leeth R, Griffey S, Kohn J (2019) Extracellular matrix derived from chondrocytes promotes rapid expansion of human primary chondrocytes in vitro with reduced dedifferentiation. Acta Biomater 85:75–83PubMedGoogle Scholar
  70. Mayorca-Guiliani AE, Madsen CD, Cox TR, Horton ER, Venning FA, Erler JT (2017) ISDoT: in situ decellularization of tissues for high-resolution imaging and proteomic analysis of native extracellular matrix. Nat Med 23:890–898PubMedGoogle Scholar
  71. Merl-Pham J, Basak T, Knüppel L, Ramanujam D, Athanason M, Behr J, Engelhardt S, Eickelberg O, Hauck SM, Vanacore R, Staab-Weijnitz CA (2019) Quantitative proteomic profiling of extracellular matrix and site-specific collagen post-translational modifications in an in vitro model of lung fibrosis. Matrix Biology Plus 1:100005Google Scholar
  72. Mullenbrock S, Liu F, Szak S, Hronowski X, Gao B, Juhasz P, Sun C, Liu M, McLaughlin H, Xiao Q, Feghali-Bostwick C, Zheng TS (2018) Systems analysis of transcriptomic and proteomic profiles identifies novel regulation of fibrotic programs by miRNAs in pulmonary fibrosis fibroblasts. Genes (Basel) 9:588Google Scholar
  73. Mullin NK, Mallipeddi NV, Hamburg-Shields E, Ibarra B, Khalil AM, Atit RP (2017) Wnt/β-catenin signaling pathway regulates specific lncRNAs that impact dermal fibroblasts and skin fibrosis. Front Genet 8:183PubMedPubMedCentralGoogle Scholar
  74. Naba A, Clauser KR, Hoersch S, Liu H, Carr SA, Hynes RO (2012) The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Mol Cell Proteomics MCP 11:M111.014647PubMedGoogle Scholar
  75. Naba A, Clauser KR, Lamar JM, Carr SA, Hynes RO (2014a) Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters. elife 3:e01308PubMedPubMedCentralGoogle Scholar
  76. Naba A, Clauser KR, Whittaker CA, Carr SA, Tanabe KK, Hynes RO (2014b) Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver. BMC Cancer 14:518–518PubMedPubMedCentralGoogle Scholar
  77. Naba A, Clauser KR, Ding H, Whittaker CA, Carr SA, Hynes RO (2016) The extracellular matrix: tools and insights for the “omics” era. Matrix Biol 49:10–24PubMedGoogle Scholar
  78. Naba A, Clauser KR, Mani DR, Carr SA, Hynes RO (2017a) Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression. Sci Rep 7:40495PubMedPubMedCentralGoogle Scholar
  79. Naba A, Pearce OMT, Del Rosario A, Ma D, Ding H, Rajeeve V, Cutillas PR, Balkwill FR, Hynes RO (2017b) Characterization of the extracellular matrix of Normal and diseased tissues using proteomics. J Proteome Res 16:3083–3091PubMedGoogle Scholar
  80. Najafi M, Farhood B, Mortezaee K (2019) Extracellular matrix (ECM) stiffness and degradation as cancer drivers. J Cell Biochem 120:2782–2790PubMedGoogle Scholar
  81. Nath S, Ghatak D, Das P, Roychoudhury S (2015) Transcriptional control of mitosis: deregulation and Cancer. Front Endocrinol 6:60Google Scholar
  82. Nawy T (2018) A pan-cancer atlas. Nat Methods 15:407PubMedGoogle Scholar
  83. Ojalill M, Parikainen M, Rappu P, Aalto E, Jokinen J, Virtanen N, Siljamaki E, Heino J (2018a) Integrin alpha2beta1 decelerates proliferation, but promotes survival and invasion of prostate cancer cells. Oncotarget 9:32435–32447PubMedPubMedCentralGoogle Scholar
  84. Ojalill M, Rappu P, Siljamaki E, Taimen P, Bostrom P, Heino J (2018b) The composition of prostate core matrisome in vivo and in vitro unveiled by mass spectrometric analysis. Prostate 78:583–594PubMedGoogle Scholar
  85. Ojalill M, Rappu P, Siljamäki E, Taimen P, Boström P, Heino J (2018c) The composition of prostate core matrisome in vivo and in vitro unveiled by mass spectrometric analysis. Prostate 78:583–594PubMedGoogle Scholar
  86. Ojalill M, Virtanen N, Rappu P, Siljamäki E, Taimen P, Heino J (2020) Interaction between prostate cancer cells and prostate fibroblasts promotes accumulation and proteolytic processing of basement membrane proteins. Prostate 80:715–726PubMedGoogle Scholar
  87. Ong S, Mann M (2006) A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC). Nat Protoc 1:2650–2660PubMedGoogle Scholar
  88. Pang X, Xie R, Zhang Z, Liu Q, Wu S, Cui Y (2019) Identification of SPP1 as an extracellular matrix signature for metastatic castration-resistant prostate Cancer. Front Oncol 9:924PubMedPubMedCentralGoogle Scholar
  89. Pearce OMT, Delaine-Smith R, Maniati E, Nichols S, Wang J, Böhm S, Rajeeve V, Ullah D, Chakravarty P, Jones RR et al (2018a) Deconstruction of a metastatic tumor microenvironment reveals a common matrix response in human cancers. Cancer Discov 8:304–319PubMedGoogle Scholar
  90. Pearce OMT, Delaine-Smith R, Maniati E, Nichols S, Wang J, Böhm S, Rajeeve V, Ullah D, Chakravarty P, Jones RR et al (2018b) Deconstruction of a metastatic tumor microenvironment reveals a common matrix response in human cancers. Cancer Discov 8:304–319PubMedGoogle Scholar
  91. Peeney D, Fan Y, Nguyen T, Meerzaman D, Stetler-Stevenson WG (2019) Matrisome-associated gene expression patterns correlating with TIMP2 in Cancer. Sci Rep 9:1–14Google Scholar
  92. Peixoto P, Etcheverry A, Aubry M, Missey A, Lachat C, Perrard J, Hendrick E, Delage-Mourroux R, Mosser J, Borg C et al (2019) EMT is associated with an epigenetic signature of ECM remodeling genes. Cell Death Dis 10:1–17Google Scholar
  93. Penet M, Kakkad S, Pathak AP, Krishnamachary B, Mironchik Y, Raman V, Solaiyappan M, Bhujwalla ZM (2017) Structure and function of a prostate Cancer dissemination–permissive extracellular matrix. Clin Cancer Res 23:2245–2254PubMedGoogle Scholar
  94. Poltavets V, Kochetkova M, Pitson SM, Samuel MS (2018) The role of the extracellular matrix and its molecular and cellular regulators in Cancer cell plasticity. Front Oncol 8:431PubMedPubMedCentralGoogle Scholar
  95. Praktiknjo SD, Obermayer B, Zhu Q, Fang L, Liu H, Quinn H, Stoeckius M, Kocks C, Birchmeier W, Rajewsky N (2020) Tracing tumorigenesis in a solid tumor model at single-cell resolution. Nat Commun 11:1–12Google Scholar
  96. Qin X, Xu H, Gong W, Deng W (2015) The tumor cytosol miRNAs, fluid miRNAs, and exosome miRNAs in lung Cancer. Front Oncol 4:357PubMedPubMedCentralGoogle Scholar
  97. Rogers LD, Overall CM (2013) Proteolytic post-translational modification of proteins: proteomic tools and methodology. Mol Cell Proteomics 12:3532–3542PubMedPubMedCentralGoogle Scholar
  98. Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S, Khainovski N, Pillai S, Dey S, Daniels S et al (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 3:1154–1169PubMedGoogle Scholar
  99. Röst HL, Sachsenberg T, Aiche S, Bielow C, Weisser H, Aicheler F, Andreotti S, Ehrlich H, Gutenbrunner P, Kenar E et al (2016) OpenMS: a flexible open-source software platform for mass spectrometry data analysis. Nat Methods 13:741–748PubMedGoogle Scholar
  100. Sanchez-Vega F, Mina M, Armenia J, Chatila WK, Luna A, La KC, Dimitriadoy S, Liu DL, Kantheti HS, Saghafinia S et al (2018) Oncogenic signaling pathways in the Cancer genome atlas. Cell 173:321–337.e10PubMedPubMedCentralGoogle Scholar
  101. Santi A, Kugeratski FG, Zanivan S (2018) Cancer associated fibroblasts: the architects of stroma remodeling. Proteomics 18:e1700167PubMedGoogle Scholar
  102. Sathe A, Grimes SM, Lau BT, Chen J, Suarez C, Huang RJ, Poultsides G, Ji HP (2020) Single-cell genomic characterization reveals the cellular reprogramming of the gastric tumor microenvironment. Clin Cancer Res 26:2640–2653PubMedPubMedCentralGoogle Scholar
  103. Schiller HB, Fernandez IE, Burgstaller G, Schaab C, Scheltema RA, Schwarzmayr T, Strom TM, Eickelberg O, Mann M (2015) Time- and compartment-resolved proteome profiling of the extracellular niche in lung injury and repair. Mol Syst Biol 11:819PubMedPubMedCentralGoogle Scholar
  104. Shao X, Taha IN, Clauser KR, Gao Y, Naba A (2020) MatrisomeDB: the ECM-protein knowledge database. Nucleic Acids Res 48:D1136–D1144PubMedGoogle Scholar
  105. Sharma A, Jiang C, De S (2018) Dissecting the sources of gene expression variation in a pan-cancer analysis identifies novel regulatory mutations. Nucleic Acids Res 46:4370–4381PubMedPubMedCentralGoogle Scholar
  106. Siegfried Z, Simon I (2010) DNA methylation and gene expression. Wiley Interdiscip Rev Syst Biol Med 2:362–371PubMedGoogle Scholar
  107. Siljamäki E, Rappu P, Riihilä P, Nissinen L, Kähäri V, Heino J (2020) H-Ras activation and fibroblast-induced TGF-β signaling promote laminin-332 accumulation and invasion in cutaneous squamous cell carcinoma. Matrix Biol 87:26–47PubMedGoogle Scholar
  108. Simão D, Silva MM, Terrasso AP, Arez F, Sousa MFQ, Mehrjardi NZ, Šarić T, Gomes-Alves P, Raimundo N, Alves PM, Brito C (2018) Recapitulation of human neural microenvironment signatures in iPSC-derived NPC 3D differentiation. Stem Cell Rep 11:552–564Google Scholar
  109. Sipilä KH, Ranga V, Rappu P, Mali M, Pirilä L, Heino I, Jokinen J, Käpylä J, Johnson MS, Heino J (2017) Joint inflammation related citrullination of functional arginines in extracellular proteins. Sci Rep 7:1–12Google Scholar
  110. Socovich AM, Naba A (2019) The cancer matrisome: from comprehensive characterization to biomarker discovery. Semin Cell Dev Biol 89:157–166PubMedGoogle Scholar
  111. Sood D, Tang-Schomer M, Pouli D, Mizzoni C, Raia N, Tai A, Arkun K, Wu J, Black LD, Scheffler B et al (2019) 3D extracellular matrix microenvironment in bioengineered tissue models of primary pediatric and adult brain tumors. Nat Commun 10:1–14Google Scholar
  112. Taha IN, Naba A (2019) Exploring the extracellular matrix in health and disease using proteomics. Essays Biochem 63:417–432PubMedGoogle Scholar
  113. Tak I, Ali F, Dar JS, Magray AR, Ganai BA, Chishti MZ (2019) Chapter 1 – Posttranslational modifications of proteins and their role in biological processes and associated diseases. In: Dar TA, Singh LR (eds) Protein modificomics. Academic Press, Cambridge, pp 1–35Google Scholar
  114. Thankam FG, Boosani CS, Dilisio MF, Dietz NE, Agrawal DK (2016) MicroRNAs associated with shoulder tendon Matrisome disorganization in Glenohumeral arthritis. PLoS One 11:e0168077PubMedPubMedCentralGoogle Scholar
  115. Thompson A, Schäfer J, Kuhn K, Kienle S, Schwarz J, Schmidt G, Neumann T, Hamon C (2003) Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. Anal Chem 75:1895–1904PubMedGoogle Scholar
  116. Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang T, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA et al (2018) The immune landscape of cancer. Immunity 48:812–830.e14PubMedPubMedCentralGoogle Scholar
  117. Tian C, Clauser KR, Öhlund D, Rickelt S, Huang Y, Gupta M, Mani DR, Carr SA, Tuveson DA, Hynes RO (2019) Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cells. PNAS 116:19609–19618PubMedGoogle Scholar
  118. Tian C, Öhlund D, Rickelt S, Lidström T, Huang Y, Hao L, Zhao RT, Franklin O, Bhatia SN, Tuveson DA, Hynes RO (2020) Cancer cell-derived Matrisome proteins promote metastasis in pancreatic ductal adenocarcinoma. Cancer Res 80:1461–1474PubMedPubMedCentralGoogle Scholar
  119. Ting DT, Wittner BS, Ligorio M, Vincent Jordan N, Shah AM, Miyamoto DT, Aceto N, Bersani F, Brannigan BW, Xega K et al (2014) Single-cell RNA sequencing identifies extracellular matrix gene expression by pancreatic circulating tumor cells. Cell Rep 8:1905–1918PubMedPubMedCentralGoogle Scholar
  120. Tomaru Y, Hayashizaki Y (2006) Cancer research with non-coding RNA. Cancer Sci 97:1285–1290PubMedGoogle Scholar
  121. Tomko LA, Hill RC, Barrett A, Szulczewski JM, Conklin MW, Eliceiri KW, Keely PJ, Hansen KC, Ponik SM (2018) Targeted matrisome analysis identifies thrombospondin-2 and tenascin-C in aligned collagen stroma from invasive breast carcinoma. Sci Rep 8:1–11Google Scholar
  122. Triulzi T, Casalini P, Sandri M, Ratti M, Carcangiu ML, Colombo MP, Balsari A, Ménard S, Orlandi R, Tagliabue E (2013) Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast Cancer subtype likely to Progress. PLoS One 8:e56761PubMedPubMedCentralGoogle Scholar
  123. Tyanova S, Temu T, Cox J (2016) The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat Protoc 11:2301–2319PubMedGoogle Scholar
  124. Walker C, Mojares E, del Río Hernández A (2018) Role of extracellular matrix in development and Cancer progression. Int J Mol Sci 19:3028PubMedCentralGoogle Scholar
  125. Wang M, You J, Bemis KG, Tegeler TJ, Brown DPG (2008) Label-free mass spectrometry-based protein quantification technologies in proteomic analysis. Brief Funct Genomics 7:329–339Google Scholar
  126. Wang M, Zhao J, Zhang L, Wei F, Lian Y, Wu Y, Gong Z, Zhang S, Zhou J, Cao K et al (2017) Role of tumor microenvironment in tumorigenesis. J Cancer 8:761–773PubMedPubMedCentralGoogle Scholar
  127. Yalak G, Vogel V (2012) Extracellular phosphorylation and phosphorylated proteins: not just curiosities but physiologically important. Sci Signal 5:re7PubMedGoogle Scholar
  128. Yang Y, Teng Z, Meng S, Yu W (2016) Identification of potential key lncRNAs and genes associated with aging based on microarray data of adipocytes from mice. Res Int 2016:9181702Google Scholar
  129. Yuzhalin AE, Gordon-Weeks AN, Tognoli ML, Jones K, Markelc B, Konietzny R, Fischer R, Muth A, O’Neill E, Thompson PR et al (2018a) Colorectal cancer liver metastatic growth depends on PAD4-driven citrullination of the extracellular matrix. Nat Commun 9:4783PubMedPubMedCentralGoogle Scholar
  130. Yuzhalin AE, Urbonas T, Silva MA, Muschel RJ, Gordon-Weeks AN (2018b) A core matrisome gene signature predicts cancer outcome. Br J Cancer 118:435–440PubMedPubMedCentralGoogle Scholar
  131. Zhang W, Ota T, Shridhar V, Chien J, Wu B, Kuang R (2013) Network-based survival analysis reveals subnetwork signatures for predicting outcomes of ovarian cancer treatment. PLoS Comput Biol 9:e1002975PubMedPubMedCentralGoogle Scholar
  132. Zhang M, Fujiwara K, Che X, Zheng S, Zheng L (2017) DNA methylation in the tumor microenvironment. J Zhejiang Univ Sci B 18:365–372PubMedPubMedCentralGoogle Scholar
  133. Zhang HE, Hamson EJ, Koczorowska MM, Tholen S, Chowdhury S, Bailey CG, Lay AJ, Twigg SM, Lee Q, Roediger B et al (2019) Identification of novel natural substrates of fibroblast activation protein-alpha by differential Degradomics and proteomics. Mol Cell Proteomics 18:65–85PubMedGoogle Scholar
  134. Zhu S, Zhang X, Weichert-Leahey N, Dong Z, Zhang C, Lopez G, Tao T, He S, Wood AC, Oldridge D et al (2017) LMO1 synergizes with MYCN to promote neuroblastoma initiation and metastasis. Cancer Cell 32:310–323.e5PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Faculty of Biochemistry and Molecular MedicineUniversity of OuluOuluFinland
  2. 2.Finnish Cancer InstituteHelsinkiFinland
  3. 3.Department of BiochemistryUniversity of TurkuTurkuFinland

Personalised recommendations